The Food and Drug Administration on Wednesday authorized Covid vaccine booster shots made by Johnson & Johnson and Moderna, another critical step in distributing the extra doses in the U.S.
Americans will also be allowed to âmix and matchâ vaccines, getting a booster shot from a different drugmaker than the one that made their initial doses
The ruling now goes to the Centers for Disease Control and Prevention and its vaccine advisory committee, which has scheduled a meeting Thursday to discuss Modernaâs and J&Jâs booster data
The authorization would open up booster doses to the more than 15 million people who have been inoculated with J&Jâs shots and the more than 69 million people who have been fully immunized with Modernaâs vaccine
Strategy: Our Algo sees MRNA climbing to at least $400 per share in 2022. We see JNJ climbing to $195 per share
AlgoTrader 